Over 5 million American citizens are at present living with Alzheimer’s disease. Researchers guess that ten percent of people over the age of sixty five and fifty percent of people over the age of 85 have the illness. US citizens are living longer, and a complete generation of Baby Boomers is heading into retirement. Accordingly, the quantity of North Americans with Alzheimer’s disease is predicted to triple by 2050. Such an amazing number of US citizens with Alzheimer’s disease will comprise a huge monetary burden on the health care system in this country. Today, the once a year price of caring for people in the U.S. with Alzheimer’s disease is close to $100 billion, and American companies lose close to $60 billion as a consequence of the illness.
More than half the $60 billion loss that companies sustain occurs as a consequence of the problems caregivers face balancing their work and the wants of their friends. Caregivers shoulder an amazing monetary burden themselves. Roughly 70% of Alzheimer’s patients live at home at a price of as much as $20,000 a year each. Nursing facilities, which are commonly obligatory for patients in the last stages of the illness, cost a mean of $42,000 a year. Financial difficulty is nothing, when put next to the physical, psychological, and emotional problems that patients with Alzheimer’s disease and their caregivers face.
A reported ten percent of Americans have a member of the family with the disease and as much as a 3rd of North Americans know somebody with it. From a clinical viewpoint, Alzheimer’s disease leads to total cognitive impairment, loss of all functional capability and, eventually, death. From a caregivers perspective, the illness slowly takes the mind of a family member, leaving only a body behind. While Alzheimer’s disease is a comparatively slow process of degeneration, the illness cuts a patient’s survival expectancy from the time when they’re diagnosed in half.
As an example, a sixty-eight years old patient who would have died at eighty-four is more likely to die at seventy-six. Additionally, the final 8 years of their life would be spent slowly losing the facility to think, move and even smile. A quick look at statistics illustrate that Alzheimer’s disease is not just an illness that has effects on older people. It has effects on everyone – black and white, old and young. The necessity for scientists to grasp the way to forestall, treat, or even cure the illness is critically necessary to the healthiness of our country and the planet.
While a remedy for Alzheimer’s remains as elusive, even delaying the beginning of illness symptoms by 5 years could cut the quantity of people with Alzheimer’s disease in half by 2055. Figures like these stress the significance of early detection. Up to date research suggests that sophisticated technology – e.g., MRIs and PET scans – may permit doctors to spot structural changes in the brain related to Alzheimer’s disease before symptoms even begin, and other researchers are looking for markers of the illness in spinal and cerebral liquid.